Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Dry needling in addition to epidural steroid injections: Under strict aseptic precautions and fluoroscopic guidance, triamcinolone acetonide injection 40mg with 0.25 percent bupivacaine
Sponsors
SGRD
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with history of back pain more than 3 months. 2.No Red Flags (neurological deficit: weakness, numbness, bladder or bowel changes, unexplained weight loss etc.). 3.ASA Physical Status I or II. 4.Failure of conservative therapy. 5.Willingness to participate and comply with the study protocol.
Exclusion criteria
Exclusion criteria: 1.History of spinal surgery or trauma. 2.Local infection at the injection site. 3.Coagulopathy or bleeding disorders. 4.Known allergy to steroids or local anaesthetics. 5.Patients with Cognitive Impairment. 6.Patients on steroid medications. 7.Patients with previous history of epidural steroid injections. 8.Patients with severe depression
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analgesic efficacy in patients receiving epidural steroid injections.Timepoint: Patients will be observed in the Post-Anaesthesia Care Unit for one hour immediately after the procedure and followed up at 1, 2, 3, 4, 8, and 12 weeks after the procedure using the VAS score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional outcome in patients with chronic low back pain.Timepoint: Quality of life will be assessed using EQ-5D-SL and depression using PHQ-9 scores followed up at 1, 2, 3, 4, 8, and 12 weeks after the procedure. Requirement of repeat block is assessed using NASS score 4, 8, and 12 weeks after the procedure. | — |
Countries
India
Contacts
Public ContactDr Ekjot Kaur
Outcome results
None listed